Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | -.--% | -.--% | -.--% |
Business Summary
Sales per Business
CAD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Health Services
63.1
%
| 7 | 92.7 % | 8 | 63.1 % | +8.72% |
Medical Cannabis
36.0
%
| 0 | 4.6 % | 5 | 36.0 % | +1,145.13% |
Wellness Products
0.9
%
| 0 | 2.7 % | 0 | 0.9 % | -49.80% |
Sales per region
CAD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Latin America
88.0
%
| 8 | 100.0 % | 11 | 88.0 % | +40.50% |
Europe
12.0
%
| 0 | 0.0 % | 2 | 12.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Álvaro Torres
FOU | Founder | 45 | 12-05-15 |
Michael O’Connor
DFI | Director of Finance/CFO | 57 | 23-04-16 |
Compliance Officer | 62 | - | |
Manuel Buendia
COO | Chief Operating Officer | - | - |
Jairo Espinoza
CTO | Chief Tech/Sci/R&D Officer | - | - |
Carolina Gomez
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | - | 19-09-30 | |
- | - | ||
Andres Galofre
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 81 | 18-07-16 | |
Álvaro Torres
FOU | Founder | 45 | 12-05-15 |
Alvaro Yañez
BRD | Director/Board Member | 46 | 07-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 232,409,396 | 228,143,919 ( 98.16 %) | 0 | 98.16 % |
Company contact information
Khiron Life Sciences Corp.
500 Burrard Street Suite 2300
V6C 2B5, Vancouver
+647 556-5750
http://www.khiron.caSector
Sales per Business
Sales per region
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 6.8M | |
+40.09% | 6.16B | |
-16.34% | 4.46B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B |
- Stock Market
- Equities
- KHRN.H Stock
- Company Khiron Life Sciences Corp.